EUVIMEDEUVIMED entdecken
Open Access

ASOBIOTICS 2024: an interdisciplinary symposium on antisense-based programmable RNA antibiotics

Jörg Vogel, Franziska Faber iD, Lars Barquist iD, Anke Sparmann iD, Linda Popella iD, Chandradhish Ghosh iD

RNA · 2025

DOI: 10.1261/rna.080347.124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RNA, 2025. Verfasst von Jörg Vogel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), D-97080 Würzburg, Germany joerg.vogel@uni…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Oligonucleotides, Antisense, RNA, Antisense. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The international symposium ASOBIOTICS 2024 brought together scientists across disciplines to discuss the challenges of advancing antibacterial antisense oligomers (ASOs) from basic research to clinical application. Hosted by the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, Germany, on September 12–13, 2024, the event featured presentations covering major milestones and current challenges of this antimicrobial technology and its applications against pathogens, commensals, and bacterial viruses. General design principles and modification of ASOs based on peptide nucleic acid (PNA) or phosphorodiamidate-morpholino-oligomer (PMO) chemistry, promising cellular RNA targets, new delivery technologies, as well as putative resistance mechanisms, were discussed. A panel discussion noted the challenge of nomenclature: antibacterial ASOs lack a single, universally used name. To address this, the term “asobiotics” was proposed to unite a community of like-minded scientists that are committed to advancing ASOs as antimicrobials. A consistent name will simplify literature searches and help scientists and funders appreciate the potential of programmable RNA antibiotics to combat antimicrobial resistance and enable precise microbiome editing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsOligonucleotides, AntisenseRNA, AntisenseAnimalsHumansBacteriaPeptide Nucleic Acids

Stichwörter der Autor:innen

antibioticsantisense oligonucleotidemicrobiome editingmorpholinopeptide nucleic acidphage

Substanzen

Anti-Bacterial AgentsOligonucleotides, AntisensePeptide Nucleic AcidsRNA, Antisense

Autor:innen und Institutionen

  • Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), D-97080 Würzburg, Germany joerg.vogel@uni-wuerzburg.de.
  • University of Würzburg, Medical Faculty, Institute of Molecular Infection Biology (IMIB), D-97080 Würzburg, Germany.
  • Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), D-97080 Würzburg, Germany.
  • University of Würzburg, Medical Faculty, Institute for Hygiene and Microbiology, D-97080 Würzburg, Germany.
  • Department of Biology, University of Toronto, Mississauga, Ontario, Canada L5L 1C6.

ORCID-Profile: Franziska Faber, Lars Barquist, Anke Sparmann, Linda Popella, Chandradhish Ghosh

Zitieren

APA

Vogel, J., Faber, F., Barquist, L., Sparmann, A., Popella, L., & Ghosh, C. (2025). ASOBIOTICS 2024: an interdisciplinary symposium on antisense-based programmable RNA antibiotics. RNA. https://doi.org/10.1261/rna.080347.124

Vancouver

Vogel J, Faber F, Barquist L, Sparmann A, Popella L, Ghosh C. ASOBIOTICS 2024: an interdisciplinary symposium on antisense-based programmable RNA antibiotics. RNA. 2025. doi:10.1261/rna.080347.124

BibTeX
@article{Vogel2025,
  author = {Vogel, Jörg and Faber, Franziska and Barquist, Lars and Sparmann, Anke and Popella, Linda and Ghosh, Chandradhish},
  title = {ASOBIOTICS 2024: an interdisciplinary symposium on antisense-based programmable RNA antibiotics},
  journal = {RNA},
  year = {2025},
  doi = {10.1261/rna.080347.124}
}
Kostenlos starten →